218 related articles for article (PubMed ID: 33706324)
1. Clinicopathological Features, Prognostic Factors, Survival Trends, and Treatment of Malignant Ovarian Germ Cell Tumors: A SEER Database Analysis.
Guo H; Chen H; Wang W; Chen L
Oncol Res Treat; 2021; 44(4):145-153. PubMed ID: 33706324
[TBL] [Abstract][Full Text] [Related]
2. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.
Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C
Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis].
Liu Y; Ren T; Feng FZ; Wan XR; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and clinic-pathologic characteristics of ovarian tumor with different histologic subtypes-a SEER database population study of 41,376 cases.
Shao C; Guo H; Chen L; Chen J; Wang L; Wang H
Transl Cancer Res; 2023 Aug; 12(8):1937-1950. PubMed ID: 37701106
[TBL] [Abstract][Full Text] [Related]
5. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
[TBL] [Abstract][Full Text] [Related]
6. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.
Wang J; Chen R; Li J; Lu X
Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
Zhang C; Xi X
Oncol Res Treat; 2023; 46(11):476-492. PubMed ID: 37857263
[TBL] [Abstract][Full Text] [Related]
8. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
Xu W; Li Y
Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
[TBL] [Abstract][Full Text] [Related]
9. [Malignant ovarian germ cell tumors--clinical characteristics and analysis of outcomes].
Miedzińska-Maciejewska M; Bobkiewicz P; Gawrychowski K
Ginekol Pol; 2011 May; 82(5):338-43. PubMed ID: 21851031
[TBL] [Abstract][Full Text] [Related]
10. Malignant ovarian germ cell tumor - role of surgical staging and gonadal dysgenesis.
Lin KY; Bryant S; Miller DS; Kehoe SM; Richardson DL; Lea JS
Gynecol Oncol; 2014 Jul; 134(1):84-9. PubMed ID: 24836278
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features and Survival Outcomes in Children and Adolescents With Malignant Mediastinal Germ Cell Tumors Based on Surveillance, Epidemiology, and End Results Database Analysis.
Wu P; Yang Y; Yu Z; Zhao L; Feng S
J Surg Res; 2023 Aug; 288():362-371. PubMed ID: 37062232
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).
Solheim O; Gershenson DM; Tropé CG; Rokkones E; Sun CC; Weedon-Fekjaer H; Fosså SD
Eur J Cancer; 2014 Jul; 50(11):1942-50. PubMed ID: 24857045
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
15. Fertility-preserving surgery for advanced stage ovarian germ cell tumors.
Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
Gynecol Oncol; 2017 Dec; 147(3):493-496. PubMed ID: 29021083
[TBL] [Abstract][Full Text] [Related]
16. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
[TBL] [Abstract][Full Text] [Related]
17. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.
Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM
Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136
[TBL] [Abstract][Full Text] [Related]
18. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
Solheim O; Kærn J; Tropé CG; Rokkones E; Dahl AA; Nesland JM; Fosså SD
Gynecol Oncol; 2013 Nov; 131(2):330-5. PubMed ID: 24001518
[TBL] [Abstract][Full Text] [Related]
19. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
Wang J; Li J; Chen R; Lu X
Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery in advanced stage malignant ovarian germ cell tumors.
Karalok A; Comert GK; Kilic C; Turkmen O; Kilic F; Basaran D; Boyraz G; Tekin ÖM; Turan T
J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):461-466. PubMed ID: 31228608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]